# The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)

> **NCT05100719** · NA · NOT_YET_RECRUITING · sponsor: **University of Pecs** · enrollment: 200 (estimated)

## Conditions studied

- Irritable Bowel Syndrome
- Lactose Intolerance
- Lactose Malabsorption

## Interventions

- **DRUG:** alverine-citrate + simethicone and lactase
- **DRUG:** alverin-citrate + simethicone with placebo

## Key facts

- **NCT ID:** NCT05100719
- **Lead sponsor:** University of Pecs
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-09
- **Primary completion:** 2026-09
- **Final completion:** 2026-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05100719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05100719, "The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT05100719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*